Innovation, Quality & Collaboration
for a Healthier World
With the constant acceleration in the pace of work and life, the incidence of mental and neurological disorders has also risen sharply. As the burden of mental disorders grows across the world, our work and quality of life have suffered, which in turn leads to serious social, human rights, and economic repercussions.
Mental disorders include: depression, schizophrenia, dementia, etc.
Patients with mental disorders are often found to be suffering from immense physical and emotional pains, which affects normal activities of daily life, and places a heavy burden on the patients and their families.
Kanghong Pharmaceutical hopes to provide patients with safer, more effective and convenient medicines through innovation, as well as improve the quality of life of patients and their families. For example, Alzheimer's disease is a progressive disease in the field of dementia, for which there is currently no effective cure. There are only 4 approved therapeutic drugs which can improve symptoms to a certain extent, but are unable to stop the progression of the disease.
Effective drugs developed by Kanghong Pharmaceutical based on current clinical experience in the treatment of Alzheimer's disease have entered Phase II clinical studies in China.
In addition, we are paying close attention to the diagnosis and treatment of mental health issues in underdeveloped regions, and we are striving to promote the improvement of such diagnosis and treatment in these areas through open classes and academic exchanges.